DexCom Inc. [DXCM] Stock trading around $80.96 per share: What’s Next?
Company DexCom [NASDAQ: DXCM] The trading session closed at $80.96 on 09/22/22. Today’s price range saw the stock record a low of $79.71, while a high of $83.85. Company report on September 1, 2022 Dexcom announces upcoming conference presentations.
While finding safe stocks with the potential for huge gains isn’t always easy, we’ve found a few that can pay off well. In fact, within our report, Top 5 cheap stocks to own right nowIn this article, we have identified five stocks that we believe can increase in value even if you have $1,000 to invest.
DexCom, Inc. announced. (NASDAQ:DXCM) today that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will provide an update on the company at the following investor conferences:.
Wells Fargo 2022 Healthcare Conference on Wednesday, September 7, 2022 at 2:35 pm (EST).
The stock has a year-to-date performance of -39.69 percent and a weekly performance of -11.01 percent. The stock has moved at -27.93 percent over the past six months. The stock has performed -3.19 percent in the last 30 days and changed by 7.65 percent in the last three months.
If compared to the average trading volume of 2.59 million shares, DXCM reached a volume of 2697198 on the last trading day, which is why market watchers consider the stock to be active.
Here’s what leading stock market experts are saying about DexCom Inc. [DXCM]:
Based on careful and fact-backed analyzes by Wall Street experts, the current consensus on DXCM’s stock price target is $98.93 per share. Target price analysis and stock performance are usually carefully studied by market experts, and the current Wall Street consensus for DXCM stock is a set recommendation at 1.60. This rating represents a strong buy recommendation, on a scale of 1 to 5, where 5 means strong sell, 4 represents sell, 3 represents hold, and 2 indicates buy.
Bernstein made an appreciation for the stock of DexCom Inc. , retaining their opinion of the stock as Outperform, with their previous recommendation back on July 15, 2022. While these analysts held the previous recommendation, BofA Securities raised its buy target price. The new note about price target was released on March 02, 2022, which is the official target price for DexCom Inc.’s stock. Previously, the target price had received another increase to $535, while BTIG Research analysts maintained a buy rating on DXCM stock.
The Average True Range (ATR) is set by DexCom Inc. at 3.46, with a price-to-sales ratio for DXCM’s stock in the last twelve months at 12.01. The price-to-book ratio for the last quarter was 14.08, with the price-to-cash per share for the same quarter set at 6.95. DXCM’s free cash flow rate for the past 12 months was 148.94 with a Q4 quick ratio of 4.30.
DXCM stock trading performance evaluation
Company DexCom [DXCM] It fell into the red at the end of last week, fell in a negative direction and fell by -11.01. With this latest performance, DXCM shares are down -3.19% over the past four-week period, and also -27.93% over the past six months – not to mention a -43.23% drop in the last year of trading.
Overbought and oversold stocks can be easily tracked by the Relative Strength Index (RSI), where an RSI result of over 70 is overbought, and any price below 30 indicates oversold conditions. The RSI of 50 represents neutral momentum in the market. The current RSI for DXCM stock in the past two-week period is set at 38.91, with the RSI for the last one traded at 31.46, and the three-week RSI is set at 43.06 for DexCom Inc. [DXCM]. The current moving average for the last 50 trading days of this stock is 86.07, while it was recorded at 86.16 for the last trading week, and 99.28 for the last 200 days.
Company DexCom [DXCM]: Insight into the basic fundamentals
Operating margin for any stock indicates how profitable the investment is, DexCom Inc. [DXCM] The stock currently has an operating margin of +10.86 and a gross margin of +68.63. DexCom Inc.’s net profit margin was reported. Currently at +6.32.
The return on equity for this stock rose to 7.59, with the return on assets remaining at 3.35.
DexCom Inc.’s liquidity data is Interesting too, with the quick ratio at 4.30 and the current ratio at 4.70.
Earnings per share (EPS) analysis for DexCom Inc. [DXCM] stock
The company’s progress can be seen through the perspective of the EPS growth rate, while Wall Street analysts focus on forecasting the 5-year EPS growth rate for DXCM. When it comes to the stated value, analysts expect DexCom Inc.’s 5-year EPS growth rate to rise. to 31.40%.
Company DexCom [DXCM]: Insiders ownership positions
There are currently approximately $32,410 million, or 96.40% of DXCM’s shares, in the hands of institutional investors. The three largest corporate owners of DXCM shares are: VANGUARD GROUP INC, with an ownership of 43,170,869, which is approximately 2.293% of the company’s market capitalization and about 0.10% of the total institutional ownership; GOLDMAN SACHS GROUP INC., which owns 3,513,389 shares with an approximate value of $2.85 billion in DXCM stock; and BLACKROCK INC. , currently owns $2.71 billion in DXCM shares with ownership of approximately -0.933% of the company’s market capitalization.
Positions in DexCom Inc shares increased. held by institutional investors at the end of July and at the time of the July report, as 405 institutional owners consolidated their positions in DexCom Inc. [NASDAQ:DXCM] About 54,842,099 shares. In addition, 433 investors decreased positions by 3,0418907 shares, while 96 investors occupied positions by 315,066,178 shares. The said changes put institutional holdings at 4,032,7184 shares, according to the latest report by the Securities and Exchange Commission. The number of DXCM stock investments was 85 new institutional investors with a total of 3,109,034 shares, while 132 institutional investors sold positions amounting to 4,831,932 shares during the same period.